Tricida, Inc.·4

Jan 20, 5:18 PM ET

Otto Dawn Parsell 4

4 · Tricida, Inc. · Filed Jan 20, 2021

Insider Transaction Report

Form 4
Period: 2021-01-17
Otto Dawn Parsell
Sr VP, Clinical Development
Transactions
  • Award

    Common Stock

    2021-01-17+186,000186,000 total
    Exercise: $7.03Exp: 2031-01-16Common Stock (186,000 underlying)
Footnotes (1)
  • [F1]The option to purchase common stock will vest as follows: (a) 25% of the shares subject to the options shall vest on January 17, 2022 and (b) the remaining 75% vest in 36 equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date.

Documents

1 file
  • 4
    wf-form4_161118111603425.xmlPrimary

    FORM 4